Goldman Sachs’s Maravai LifeSciences MRVI Stock Holding History
Bought
Maintained
Sold
Other funds holding MRVI
1WCM
Goldman Sachs's MRVI Position: Q3 2026 in Review
Goldman Sachs increased its Maravai LifeSciences (MRVI) stake by 25% in Q3 2026, buying an estimated $2.78M and bringing the position to 2,043,668 shares worth $15.7M. The position accounts for ﹤0.01% of the portfolio, ranked #2783.
Goldman Sachs first reported a position in MRVI in Q4 2020 and has held it in 24 quarters since. The position peaked at $16.9M in Q3 2024. 202 funds tracked by Wall St. Rank hold MRVI as of Q3 2026.
- Goldman Sachs held 2,043,668 shares of Maravai LifeSciences worth $15.7M as of Q3 2026.
- Goldman Sachs bought 402,371 Maravai LifeSciences shares in Q3 2026, an estimated $2.78M.
- Maravai LifeSciences made up ﹤0.01% of Goldman Sachs's portfolio in Q3 2026, its #2783 holding.
- Goldman Sachs first reported a position in Maravai LifeSciences in Q4 2020 and has held it in 24 quarters since.
- Goldman Sachs's Maravai LifeSciences position peaked at $16.9M in Q3 2024.
- 202 funds tracked by Wall St. Rank held Maravai LifeSciences as of Q3 2026.
Based on Goldman Sachs's 13F filing for Q3 2026, filed 16 Nov 2026.